Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
December 17 2024 - 4:06PM
Edgar (US Regulatory)
Exhibit
1
JOINT
FILING AGREEMENT
The
undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned, and that
all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity
of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of
such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible
for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe
that such information is inaccurate.
| Dated:
December 17, 2024 |
|
| |
|
| Commodore
Capital LP |
|
| |
|
|
| By: |
/s/
Michael Kramarz |
|
| Michael
Kramarz, Managing Partner |
|
| |
|
|
| Commodore
Capital Master LP |
|
| |
|
|
| By: |
/s/
Michael Kramarz |
|
| Michael
Kramarz, Authorized Signatory |
|
Cardiff Oncology (NASDAQ:CRDF)
Historical Stock Chart
From Nov 2024 to Dec 2024
Cardiff Oncology (NASDAQ:CRDF)
Historical Stock Chart
From Dec 2023 to Dec 2024
